Results 211 to 220 of about 18,503 (241)

Anti-amyloid nanobody-Fc fusion protein drives potent amyloid clearance through microglial recruitment. [PDF]

open access: yesAlzheimers Dement (N Y)
Ding Z   +6 more
europepmc   +1 more source

Untersuchung von Anti‐Glykan‐Antikörpern und Erforschung ihres medizinischen Potenzials mithilfe synthetischer Glykane

open access: yesAngewandte Chemie, Volume 138, Issue 39, 21 September 2026.
Anti‐Glykan‐Antikörper spielen sowohl bei Gesundheit als auch bei Krankheit eine wesentliche Rolle. Der Zugang zu neuartigen Glykanstrukturen ermöglicht Fortschritte bei der Antikörpercharakterisierung für die Entdeckung von Biomarkern, die Antikörperentwicklung und das Impfstoffdesign.
Fabienne Weber   +4 more
wiley   +1 more source

A designed fusion tag improves soluble expression of nanobody in <i>E. coli</i>. [PDF]

open access: yesMagn Reson Lett
Wang X   +6 more
europepmc   +1 more source

Using Synthetic Glycans to Investigate Anti‐Glycan Antibodies and Explore Their Medical Potential

open access: yesAngewandte Chemie International Edition, Volume 65, Issue 39, 21 September 2026.
Anti‐glycan antibodies are essential in health and disease. Access to novel glycan structures paves the way for progress in antibody profiling for biomarker discovery, antibody development, and vaccine design. We summarize the strategies to synthesize and utilize synthetic glycans for the development and application of anti‐glycan antibodies in basic ...
Fabienne Weber   +4 more
wiley   +1 more source

Distinct competitive and allosteric binding modes of nanobodies targeting EphA4. [PDF]

open access: yesJ Biol Chem
Jiang H   +11 more
europepmc   +1 more source

Surface Functionalization Studies in the Development of Nanohole Plasmonic Sensors. [PDF]

open access: yesSensors (Basel)
Sayin S   +4 more
europepmc   +1 more source

High-Throughput Isolation of Nanomouse-Derived VHH Domains: A Practical Guide from Immunization to Nanobody Expression. [PDF]

open access: yesCurr Protoc
Casselman TJ   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy